QAD Inc. (Nasdaq: QADA) (Nasdaq: QADB), a leading provider of enterprise software and services designed for global manufacturing companies, today announced that SHINE Medical Technologies, Inc. (SHINE), has chosen QAD Cloud ERP.
Based in Janesville, WI, SHINE Medical Technologies is dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements. Their advanced accelerator technology enables a high-yield isotope production process that is safer, cleaner, and more affordable than existing processes.
Founded in 2010, SHINE has grown substantially and the company realized it needed an ERP system that could adapt to its changing business needs and accommodate growth. QAD Cloud ERP is a full-featured cloud ERP solution built for manufacturing. It will allow SHINE to automate and streamline its financial processes, while helping it improve internal control over financial reporting. QAD Channel Partner Strategic Information Group will assist with the QAD implementation project.
SHINE selected QAD Cloud ERP for a number of reasons including:
QAD’s experience working with companies similar to SHINE
QAD’s emphasis on partnering with its customers and focusing on continuous improvement
QAD Financials will scale as SHINE continues to grow
“Implementing the QAD solution provides a foundation that supports SHINE’s mission to be the world leader in the safe, clean, affordable production of medical isotopes,” said SHINE Financial Planning and Analysis Manager, Aaron Sprang. “We need a solution with strong financials and the ability to scale as we grow. We found the right partner in QAD.”
“We are happy to welcome SHINE Medical Technologies to the QAD family,” said QAD Senior Vice President, North America, Ed Boclair. “Growing life science customers like SHINE increasingly choose our cloud ERP solution to reduce time to deployment and drive efficiencies. SHINE competes in a highly regulated environment and QAD Cloud ERP helps reduce SHINE’s time to validation.”
For full story, Please click here.